Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Stevanato Group (STVN) stocks

Learn how to easily invest in Stevanato Group stocks.

Stevanato Group, an Italian company that makes glass vials for COVID-19 vaccines, has gone public on the NYSE. Here's how investors in Canada can buy in.

How to buy Stevanato Group stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – STVN. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners

National Bank Direct Brokerage

  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge

  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Stevanato Group stock price (NYSE:STVN)

Use our graph to track the performance of STVN stocks over time.

Stevanato Group shares at a glance

Information last updated 2023-05-28.
Latest market close$27.54
52-week range$13.71 - $29.67
50-day moving average $26.22
200-day moving average $20.23
Wall St. target price$31.47
PE ratio 45.2542
Dividend yield $0 (0.19%)
Earnings per share (TTM) $0.59

Buy Stevanato Group stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
CIBC Investor's Edge
Finder Rating:
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
National Bank Direct Brokerage
Finder Rating:
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.

Is it a good time to buy Stevanato Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Stevanato Group price performance over time

Historical closes compared with the close of $27.54 from 2023-06-01

1 week (2023-05-26) 3.15%
1 month (2023-05-03) -0.86%
3 months (2023-03-03) 8.43%
6 months (2022-12-02) 72.13%
1 year (2022-06-03) 68.96%
2 years (2021-05-30) N/A
3 years (2020-05-30) N/A
5 years (2018-05-30) N/A

Is Stevanato Group stock undervalued or overvalued?

Valuing Stevanato Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stevanato Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Stevanato Group financials

Revenue TTM $1 billion
Operating margin TTM 19.56%
Gross profit TTM $319.8 million
Return on assets TTM 7.69%
Return on equity TTM 14.99%
Profit margin 14.2%
Book value $3.89
Market capitalisation $7.1 billion

TTM: trailing 12 months

Stevanato Group share dividends


Dividend payout ratio: 9.67% of net profits

Recently Stevanato Group has paid out, on average, around 9.67% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.19% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stevanato Group shareholders could enjoy a 0.19% return on their shares, in the form of dividend payments. In Stevanato Group's case, that would currently equate to about $0 per share.

While Stevanato Group's payout ratio might seem low, this can signify that Stevanato Group is investing more in its future growth.

Stevanato Group's most recent dividend payout was on 13 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 13 June 2022 (the "ex-dividend date").

Stevanato Group's dividend payout ratio is perhaps best considered in relation to those of similar companies.

Stevanato Group overview

Stevanato Group S. p. A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site